Inside the First Unified eClinical SaaS Platform

The story behind building the industry's first unified EDC + RTSM + eCOA + Safety platform, and the lessons learned from powering 1,000+ clinical trials.

The Vision

In the early 2010s, clinical trial technology was fragmented. Sponsors bought EDC from one vendor, RTSM from another, safety from a third, and spent months integrating systems that were never designed to work together. The vision was simple: build a unified platform where all systems shared a single data model and worked seamlessly together.

The Architecture Challenge

Building a unified platform required solving fundamental architectural challenges:

Single Data Model

The core innovation was a single data model that could support EDC, RTSM, eCOA, and safety. This eliminated data reconciliation and ensured consistency across all systems.

Configurable Workflows

Clinical trials have widely varying requirements. The platform needed configurable workflows that could adapt to different study designs without custom development.

Scalability

The platform had to scale from small Phase 1 studies to global Phase 3 programs with thousands of sites and millions of data points.

Development Journey

Phase 1: Core Platform

The initial focus was on EDC and RTSM integration. These were the most critical systems and the source of the biggest integration pain points.

Phase 2: Safety Integration

Safety was added next, with bidirectional data flow between EDC and safety systems. This enabled real-time safety signal detection.

Phase 3: eCOA and Patient-Facing

eCOA and patient-facing capabilities were added to support decentralized and hybrid trial models.

Phase 4: Analytics and Reporting

Advanced analytics and reporting capabilities were added to provide real-time visibility into trial performance.

Lessons Learned

Integration is Harder Than It Looks

Even with a unified platform, integrating with external systems (labs, imaging, specialty vendors) remains challenging. APIs and data standards are critical.

User Experience Matters

The most sophisticated platform fails if site staff and patients can't use it effectively. UX design is as important as technical architecture.

Validation Never Ends

Validation is not a one-time event. Continuous validation and change management are essential for GxP compliance.

Customer Success is Product Success

The platform's success depended on customer success. Implementation support, training, and ongoing support were as important as the software itself.

The FAST Methodology

Through 1,000+ trials, we developed the FAST (Framework for Accelerated Study Setup and Timeline) methodology, achieving delivery timelines 70% faster than industry average without compromising quality. Key principles:

• Template-based study setup
• Parallel workstreams
• Early stakeholder alignment
• Risk-based testing

What This Means for Your Technology Decisions

Unified Platforms Have Matured

The unified platform model has proven itself across thousands of trials. The integration challenges that once made best-of-breed attractive have largely been solved.

Total Cost of Ownership Matters

When evaluating platforms, consider total cost of ownership including implementation, integration, validation, and ongoing support — not just license fees.

Vendor Experience Matters

Choose vendors with proven track records across similar studies. Ask for references and case studies from trials like yours.

Need Guidance on Your Technology Strategy?

A Fractional CTO with direct experience building and scaling unified eClinical platforms can help you make the right technology decisions for your trials. Schedule a free 30-minute strategy call.